TherapeuticsMD, Inc. (TXMD)
2.08
+0.03
(+1.46%)
USD |
NASDAQ |
Sep 28, 16:00
2.05
-0.03
(-1.44%)
After-Hours: 19:24
TherapeuticsMD Price to Book Value : 0.8873 for Sept. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 0.8745 |
| September 24, 2026 | 0.9086 |
| September 23, 2026 | 0.9257 |
| September 22, 2026 | 0.9214 |
| September 21, 2026 | 0.8958 |
| September 18, 2026 | 0.9342 |
| September 17, 2026 | 0.9299 |
| September 16, 2026 | 0.9299 |
| September 15, 2026 | 0.9214 |
| September 14, 2026 | 0.9214 |
| September 11, 2026 | 0.9214 |
| September 10, 2026 | 0.8958 |
| September 09, 2026 | 0.9044 |
| September 08, 2026 | 0.9129 |
| September 04, 2026 | 0.9427 |
| September 03, 2026 | 0.9555 |
| September 02, 2026 | 0.9641 |
| September 01, 2026 | 0.9257 |
| August 31, 2026 | 0.9299 |
| August 28, 2026 | 0.947 |
| August 27, 2026 | 0.947 |
| August 26, 2026 | 0.9726 |
| August 25, 2026 | 0.9726 |
| August 24, 2026 | 0.883 |
| August 21, 2026 | 0.8788 |
| Date | Value |
|---|---|
| August 20, 2026 | 0.8788 |
| August 19, 2026 | 0.866 |
| August 18, 2026 | 0.8574 |
| August 17, 2026 | 0.8574 |
| August 14, 2026 | 0.883 |
| August 13, 2026 | 0.8873 |
| August 12, 2026 | 0.8873 |
| August 11, 2026 | 0.883 |
| August 10, 2026 | 0.883 |
| August 07, 2026 | 0.883 |
| August 06, 2026 | 0.8916 |
| August 05, 2026 | 0.883 |
| August 04, 2026 | 0.8702 |
| August 03, 2026 | 0.8702 |
| July 31, 2026 | 0.866 |
| July 30, 2026 | 0.866 |
| July 29, 2026 | 0.8788 |
| July 28, 2026 | 0.8788 |
| July 27, 2026 | 0.883 |
| July 24, 2026 | 0.8788 |
| July 23, 2026 | 0.8788 |
| July 22, 2026 | 0.8617 |
| July 21, 2026 | 0.8702 |
| July 20, 2026 | 0.9001 |
| July 17, 2026 | 0.8788 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.877 |
| Corcept Therapeutics, Inc. | 17.66 |
| Veru, Inc. | 1.520 |
| Johnson & Johnson | 7.709 |
| Eli Lilly & Co. | 32.95 |
Price to Book Value Related Metrics
| PS Ratio | 7.383 |
| Price to Free Cash Flow | 7.739 |
| Price | 2.08 |
| Earnings Yield | -0.91% |
| Market Cap | 24.07M |